BioAffinity Technologies

FromJulie Anne Overton ([email protected])
Subject (97)bioAffinity Technologies Reports $2.4 Million Revenue for Q2 Driven by Growing CyPath® Lung Sales
Preheader (150)News ReleasebioAffinity Technologies Reports $2.4 Million Revenue for Q2 Driven by Growing CyPath® Lung SalesQ2 CyPath® Lung test sales up 217% over Q
Typography
Arial
Colors
Text Analysis
Body Words2247
Subject Words14
Body Emojis30
Subject Emojis1
Media Analysis
Text Links12
Image Links3
Total Links15
Images5
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px3968 px
X-Spam Score-0.0
Preheader OptimizedNo
Timing
Day of WeekWednesday
TimeEvening

bioAffinity Technologies Reports $2.4 Million Revenue for Q2 Driven by Growing CyPath® Lung Sales

News ReleasebioAffinity Technologies Reports $2.4 Million Revenue for Q2 Driven by Growing CyPath® Lung SalesQ2 CyPath® Lung test sales up 217% over Q
bioAffinity Technologies Reports $2.4 Million Revenue for Q2 Driven by Growing CyPath® Lung Sales